164 related articles for article (PubMed ID: 29194861)
1. Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.
Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio H; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
J Viral Hepat; 2018 May; 25(5):473-481. PubMed ID: 29194861
[TBL] [Abstract][Full Text] [Related]
2. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
3. The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.
Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio HM; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
J Hepatol; 2018 Mar; 68(3):393-401. PubMed ID: 29107152
[TBL] [Abstract][Full Text] [Related]
4. Trends in mortality after diagnosis of hepatitis C virus infection: an international comparison and implications for monitoring the population impact of treatment.
Aspinall EJ; Hutchinson SJ; Janjua NZ; Grebely J; Yu A; Alavi M; Amin J; Goldberg DJ; Innes H; Law M; Walter SR; Krajden M; Dore GJ
J Hepatol; 2015 Feb; 62(2):269-77. PubMed ID: 25200903
[TBL] [Abstract][Full Text] [Related]
5. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
7. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
8. Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia.
Yeoh YKJ; Dore GJ; Lockart I; Danta M; Flynn C; Blackmore C; Levy MT; George J; Alavi M; Hajarizadeh B
Intern Med J; 2024 Apr; 54(4):602-612. PubMed ID: 37819787
[TBL] [Abstract][Full Text] [Related]
9. Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales.
Shah SHBU; Alavi M; Hajarizadeh B; Matthews GV; Martinello M; Danta M; Amin J; Law MG; George J; Valerio H; Dore GJ
JHEP Rep; 2022 Oct; 4(10):100552. PubMed ID: 36119722
[TBL] [Abstract][Full Text] [Related]
10. Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.
Amin J; O'Connell D; Bartlett M; Tracey E; Kaldor J; Law M; Dore G
Aust N Z J Public Health; 2007 Oct; 31(5):475-82. PubMed ID: 17931297
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
[TBL] [Abstract][Full Text] [Related]
12. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
[TBL] [Abstract][Full Text] [Related]
13. All-cause hepatocellular carcinoma survival in the era of direct-acting antiviral therapy.
Lockart I; Hajarizadeh B; Buckley N; Davison S; Prakoso E; Levy MT; George J; Dore GJ; Danta M
J Gastroenterol Hepatol; 2021 Dec; 36(12):3515-3523. PubMed ID: 34520088
[TBL] [Abstract][Full Text] [Related]
14. Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study.
Innes H; McDonald SA; Hamill V; Yeung A; Dillon JF; Hayes PC; Went A; Fraser A; Bathgate A; Barclay ST; Janjua N; Goldberg DJ; Hutchinson SJ
Liver Int; 2022 Mar; 42(3):561-574. PubMed ID: 34951109
[TBL] [Abstract][Full Text] [Related]
15. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C.
Walter SR; Thein HH; Gidding HF; Amin J; Law MG; George J; Dore GJ
J Gastroenterol Hepatol; 2011 Dec; 26(12):1757-64. PubMed ID: 21615789
[TBL] [Abstract][Full Text] [Related]
17. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: an epidemiologic view.
El-Serag HB
J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival.
Wallace MC; Preen DB; Short MW; Adams LA; Jeffrey GP
Liver Int; 2019 Mar; 39(3):522-530. PubMed ID: 30230194
[TBL] [Abstract][Full Text] [Related]
20. Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: A large multicentre cohort study.
Mgaieth S; Kemp W; Gow P; Fink M; Lubel J; Nicoll A; Gazzola A; Hong T; Ryan M; Knight V; Dev AT; Sood S; Bell S; Paul E; Roberts SK
J Viral Hepat; 2017 Nov; 24(11):982-989. PubMed ID: 28414893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
